$WULF
TERAWULF INC. Stock $wulf

$wulf Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000143774921026741 Filed on November 15, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q4
Revenue	$0.00	$4.743M	$4.228M
YoY Change	-100.0%	51.31%	-14.77%
Cost Of Revenue	$0.00	$3.161M	$2.734M
YoY Change	-100.0%	39.81%	-20.05%
Gross Profit	$0.00	$1.582M	$1.493M
YoY Change	-100.0%	81.06%	-3.67%
Gross Profit Margin		33.35%	35.32%
Selling, General & Admin	$41.51M	$2.274M	$1.057M
YoY Change	3829.2%	132.1%	-25.6%
% of Gross Profit		143.74%	70.76%
Research & Development		$134.6K	$150.0K
YoY Change		-1.4%	-25.0%
% of Gross Profit		8.51%	10.05%
Depreciation & Amortization		$160.7K	$170.7K
YoY Change		-69.53%	0.42%
% of Gross Profit		10.16%	11.43%
Operating Expenses	$41.72M	$2.409M	$1.207M
YoY Change	3357.7%	115.77%	-25.05%
Operating Profit	-$41.72M	-$826.6K	$286.5K
YoY Change	-14662.49%	240.83%	-577.52%
Interest Expense	-$2.255M	$103.00	-$15.86K
YoY Change	14118.16%	-99.58%	-20.7%
% of Operating Profit			-5.54%
Other Income/Expense, Net		$20.00	$1.215M
YoY Change		-50.0%	12045.4%
Pretax Income	-$43.98M	-$826.7K	$1.485M
YoY Change	-3061.1%	209.53%	-1956.49%
Income Tax	-$615.0K	$25.08K	$22.00K
% Of Pretax Income			1.48%
Net Earnings	-$92.47M	-$851.7K	$1.463M
YoY Change	-6419.69%	210.86%	-1928.99%
Net Earnings / Revenue		-17.96%	34.61%
Basic Earnings Per Share		-$0.43
Diluted Earnings Per Share	-$1.106M	-$0.43	$740.3K
COMMON SHARES
Basic Shares Outstanding	1.982M	1.981M
Diluted Shares Outstanding		1.981M

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$43.45M	$1.501M	$3.694M
YoY Change	1076.23%	-57.13%	15.43%
Cash & Equivalents	$43.45M	$1.501M	$3.694M
Short-Term Investments			$0.00
Other Short-Term Assets	$108.0K	$183.5K	$126.0K
YoY Change	-14.27%	14.2%	-86.0%
Inventory		$1.650M	$1.645M
Prepaid Expenses	$1.494M
Receivables		$1.875M	$2.119M
Other Receivables		$5.330K	$219.5K
Total Short-Term Assets	$68.05M	$5.214M	$7.803M
YoY Change	772.08%	-30.25%	-10.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$91.45M	$6.933M	$7.388M
YoY Change	1137.7%	-8.17%	-6.67%
Goodwill
YoY Change
Intangibles		$232.7K	$243.6K
YoY Change
Long-Term Investments	$104.3M
YoY Change
Other Assets	$109.0K
YoY Change
Total Long-Term Assets	$196.9M	$7.166M	$7.632M
YoY Change	2479.41%	-8.11%	-6.78%
TOTAL ASSETS
Total Short-Term Assets	$68.05M	$5.214M	$7.803M
Total Long-Term Assets	$196.9M	$7.166M	$7.632M
Total Assets	$264.9M	$12.38M	$15.44M
YoY Change	1616.26%	-18.95%	-8.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.79M	$1.616M	$459.8K
YoY Change	2464.15%	251.94%	-42.52%
Accrued Expenses	$7.751M	$582.4K	$447.8K
YoY Change	1630.83%	13.31%	-55.22%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$2.688M
YoY Change		-100.0%	1917.0%
Total Short-Term Liabilities	$45.86M	$2.198M	$3.596M
YoY Change	1175.2%	-50.4%	85.89%
LONG-TERM LIABILITIES
Long-Term Debt	$94.63M	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$992.0K
YoY Change
Total Long-Term Liabilities	$94.63M	$0.00	$0.00
YoY Change		-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.86M	$2.198M	$3.596M
Total Long-Term Liabilities	$94.63M	$0.00	$0.00
Total Liabilities	$141.7M	$2.198M	$3.596M
YoY Change	3841.32%	-55.23%	-22.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$95.68M	$7.002M	$8.898M
YoY Change	-1175.36%	-5.82%	-4.71%
Common Stock	$100.0K	$3.180M	$2.942M
YoY Change	-96.6%	8.53%	0.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$123.2M	$10.18M	$11.84M
YoY Change
Total Liabilities & Shareholders Equity	$264.9M	$12.38M	$15.44M
YoY Change	1616.26%	-18.95%	-8.56%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q4
OPERATING ACTIVITIES
Net Income	-$92.47M	-$851.7K	$1.463M
YoY Change	-6419.69%	210.86%	-1928.99%
Depreciation, Depletion And Amortization		$160.7K	$170.7K
YoY Change		-69.53%	0.42%
Cash From Operating Activities	-$24.66M	-$774.1K	$231.3K
YoY Change	-10763.87%	22.85%	65.21%
INVESTING ACTIVITIES
Capital Expenditures	-$85.35M	$3.330K	-$1.940K
YoY Change	4399297.94%	-102.04%	-101.29%
Acquisitions
YoY Change
Other Investing Activities	-$92.35M	$4.800K	$0.00
YoY Change		-99.78%	-100.0%
Cash From Investing Activities	-$177.7M	$8.130K	-$1.940K
YoY Change	9159390.72%	-99.61%	-101.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	244.7M	5.960K	-36.40K
YoY Change	-672370.85%	-99.46%	-9.0%
NET CHANGE
Cash From Operating Activities	-24.66M	-774.1K	231.3K
Cash From Investing Activities	-177.7M	8.130K	-1.940K
Cash From Financing Activities	244.7M	5.960K	-36.40K
Net Change In Cash	42.35M	-760.0K	192.9K
YoY Change	21847.65%	-129.95%	-3.53%
FREE CASH FLOW
Cash From Operating Activities	-$24.66M	-$774.1K	$231.3K
Capital Expenditures	-$85.35M	$3.330K	-$1.940K
Free Cash Flow	$60.68M	-$777.4K	$233.2K
YoY Change	25918.89%	66.39%	-2432.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1981527
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	54000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	55000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	212913	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	207399	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	250000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	250000
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4750000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4750000
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1981527
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1981527
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1976354
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1976354
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10000
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1500847	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3693845	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1875177	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2119213	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	1649517	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1644975	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	183516	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	125969	USD
CY2021Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5331	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	219451	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	5214388	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	7803453	USD
CY2021Q3	iknx	Land And Building LandAndBuilding	9556586	USD
CY2020Q4	iknx	Land And Building LandAndBuilding	9556586	USD
CY2021Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5273968	USD
CY2020Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5263586	USD
CY2021Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1420494	USD
CY2020Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1417219	USD
CY2021Q3	iknx	Vehicles Vehicles	222120	USD
CY2020Q4	iknx	Vehicles Vehicles	245674	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16473168	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16483065	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9540029	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9094702	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6933139	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7388363	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	232679	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	243583	USD
CY2021Q3	us-gaap	Assets Assets	12380206	USD
CY2020Q4	us-gaap	Assets Assets	15435399	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2688396	USD
CY2021Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1615868	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	459836	USD
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	419574	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	279755	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	162861	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	168066	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2198303	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3596053	USD
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	198153	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	197635	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2981620	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2743930	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7002130	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8897781	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	10181903	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11839346	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12380206	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15435399	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4743452	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3134984	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12068208	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9204615	USD
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3161362	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2261205	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8060482	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6792709	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	1582090	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	873779	USD
	us-gaap	Gross Profit GrossProfit	4007726	USD
	us-gaap	Gross Profit GrossProfit	2411906	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2274054	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	979773	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5402147	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3963100	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	134608	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	136520	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	398425	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	521334	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-826572	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-242514	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1792846	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2072528	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	103	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	24592	USD
	us-gaap	Interest Expense InterestExpense	102443	USD
	us-gaap	Interest Expense InterestExpense	70699	USD
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	20	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	39	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	5195	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	8722	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-826655	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-267067	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1890094	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2134505	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25081	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6929	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5557	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-232000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-851736	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-273996	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1895651	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1902505	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.96
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.96
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.96
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.96
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1981138
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1976354
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1978638
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1976354
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1981138
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1976354
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1978638
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1976354
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	10954725	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-851736	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5957	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	72957	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	10181903	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	10635565	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-273996	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2762	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	10364331	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11839346	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1895651	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	33647	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	204561	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	10181903	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	12256698	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1902505	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10138	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	10364331	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1895651	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1902505	USD
	us-gaap	Depreciation Depreciation	468881	USD
	us-gaap	Depreciation Depreciation	499899	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	105764	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	27445	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	204561	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	10138	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4800	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2325	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	16906	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-244037	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1017501	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4542	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-24723	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	57548	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-746216	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-214120	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	240082	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1156032	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-302512	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	134614	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-525521	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	565468	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-630117	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13657	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	149916	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4800	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	18297	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10021	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	12976	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2205000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18878	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2060405	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1214500	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2773235	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	107554	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	33647	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2739588	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1106946	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2192998	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2537234	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3693845	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	963649	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1500847	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3500883	USD
	us-gaap	Interest Paid Net InterestPaidNet	24089	USD
	us-gaap	Interest Paid Net InterestPaidNet	56834	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	208562	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-8082	USD
CY2021Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1487128	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1323655	USD
CY2021Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	356365	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	428753	USD
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1104345	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1065458	USD
CY2021Q3	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	1298321	USD
CY2020Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	1172891	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	1649517	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1644975	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1981138
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1976354
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2020Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1981138
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1976354
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1978638
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1976354
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1978638
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1976354
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	204600	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10100	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	597000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3833
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	39800	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17500
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.50
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3833
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.78
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	10.75
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22667
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.50
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5166
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.54
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	152800	USD
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	44900	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	pure
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4743452	USD
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3161362	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	1582090	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2274054	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	134608	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-826572	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3134984	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2261205	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	873779	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	979773	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	136520	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-242514	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12068208	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8060482	USD
	us-gaap	Gross Profit GrossProfit	4007726	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5402147	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	398425	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1792846	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9204615	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6792709	USD
	us-gaap	Gross Profit GrossProfit	2411906	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3963100	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	521334	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2072528	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1875177	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2119213	USD
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.030	pure
CY2020Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.005	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.003	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.109	pure
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD

Files In Submission

Name	View Source	Status
0001437749-21-026741-index-headers.html	Edgar Link	pending
0001437749-21-026741-index.html	Edgar Link	pending
0001437749-21-026741.txt	Edgar Link	pending
0001437749-21-026741-xbrl.zip	Edgar Link	pending
ex_283859.htm	Edgar Link	pending
ex_283860.htm	Edgar Link	pending
ex_283861.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
iknx-20210930.xsd	Edgar Link	pending
iknx-20210930_cal.xml	Edgar Link	unprocessable
iknx-20210930_def.xml	Edgar Link	unprocessable
iknx-20210930_lab.xml	Edgar Link	unprocessable
iknx-20210930_pre.xml	Edgar Link	unprocessable
ikon20210930_10q.htm	Edgar Link	pending
ikon20210930_10q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WULF
TERAWULF INC. Stock $wulf

2021 Q4 Form 10-Q Financial Statement

#000143774921026741 Filed on November 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WULF TERAWULF INC. Stock $wulf

2021 Q4 Form 10-Q Financial Statement

#000143774921026741 Filed on November 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WULF
TERAWULF INC. Stock $wulf